Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 50 mg/ml;   - solution for injection - 150mg/3ml - active: amiodarone hydrochloride 50 mg/ml   excipient: benzyl alcohol polysorbate 80 water for injection - tachyarrhythmias associated with wolff-parkinson-white syndrome. all types of tachyarrhythmias including; supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; ventricular fibrillation; when other agents cannot be used. the injection is to be used when a rapid response is required.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - labetalol hydrochloride 400mg;   - film coated tablet - 400 mg - active: labetalol hydrochloride 400mg   excipient: carnauba wax lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch sodium starch glycolate

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

clinect nz pty limited - chlorpromazine hydrochloride 25 mg/ml - solution for injection - 25 mg/ml - active: chlorpromazine hydrochloride 25 mg/ml excipient: sodium chloride sodium citrate dihydrate sodium metabisulfite sodium sulfite water for injection

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

clinect nz pty limited - chlorpromazine hydrochloride 100mg - tablet - 100 mg - active: chlorpromazine hydrochloride 100mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate macrogol 200 magnesium stearate maize starch opaspray white m-1-7111b purified water  

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - chlorpromazine hydrochloride 10mg - tablet - 10 mg - active: chlorpromazine hydrochloride 10mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate macrogol 200 magnesium stearate maize starch opaspray white m-1-7111b purified water

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

clinect nz pty limited - chlorpromazine hydrochloride 25mg - tablet - 25 mg - active: chlorpromazine hydrochloride 25mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate macrogol 200 magnesium stearate maize starch opaspray white m-1-7111b purified water  

Izrael - angličtina - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - film coated tablets - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections in patients of 18 years and older• respiratory infections : - uncomplicated acute bacterial sinusitis (abs) - acute exacerbations of chronic bronchitis (aecb) megaxin tablets should be used to treat adequately diagnosed abs and aecb only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed to resolve the infection. - community acquired pneumonia, except severe cases. megaxin tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection. • community-acquired spontaneous and wound infections of the skin and skin structure.appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin tablets may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Izrael - angličtina - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - film coated tablets - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections in patients of 18 years and older• respiratory infections : - uncomplicated acute bacterial sinusitis (abs) - acute exacerbations of chronic bronchitis (aecb) megaxin tablets should be used to treat adequately diagnosed abs and aecb only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed to resolve the infection. - community acquired pneumonia, except severe cases. megaxin tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection. • community-acquired spontaneous and wound infections of the skin and skin structure.appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin tablets may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

imbat limited - amiodarone hydrochloride - tablet - 100 milligram(s) - antiarrhythmics, class iii; amiodarone

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

imbat limited - amiodarone hydrochloride - tablet - 200 milligram(s) - antiarrhythmics, class iii; amiodarone